摘要
[目的]探讨降脂化瘀汤联合水飞蓟宾葡甲胺片对痰瘀互结型非酒精性脂肪肝患者血清ALT、AST、GGT水平及血脂代谢的影响。[方法]选取我院2016年2月~2017年9月收治的106例痰瘀互结型非酒精性脂肪肝患者作为研究对象,按随机数字表法均分为治疗组(n=53)和对照组(n=53)。2组均给予基础治疗,在此基础上对照组服用水飞蓟宾葡甲胺片,治疗组在对照组基础上联合应用降脂化瘀汤进行治疗。比较2组患者临床疗效、中医证候积分、血清谷丙转氨酶(ALT)、谷草转氨酶(AST)、谷氨酰转肽酶(GGT)水平、血脂代谢状况及不良反应发生情况。[结果]治疗组总有效率92.45%较对照组的71.70%高(P<0.05);治疗后2组中医症候积分均较治疗前低(P<0.05),且治疗组均较对照组低(P<0.05);治疗后2组血清ALT、AST、GGT水平均较治疗前低(P<0.05),且治疗组较对照组低(P<0.05);治疗后2组总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(LDL-C)水平均较治疗前低(P<0.05),低密度脂蛋白胆固醇(HDL-C)水平较治疗前高(P<0.05),且2组比较差异有统计学意义(P<0.05),且治疗组TC、TG、LDL-C水平低于对照组(P<0.05),HDL-C水平高于对照组(P<0.05);治疗组与对照组不良反应发生率比较差异无统计学意义(P>0.05)。[结论]痰瘀互结型非酒精性脂肪肝患者实施降脂化瘀汤与水飞蓟宾葡甲胺片联合治疗,可显著提高临床疗效,明显下调血清ALT、AST、GGT水平,有效改善血脂代谢状况,且安全性较高。
[Objective]To investigate the influences of Jiangzhi Huayu Decoction and Silibin Meglumine Tablets on serum ALT,AST,GGT levels and blood lipid metabolism in patients with phlegm and silting stasis type non alcohol fatty liver disease.[Methods]106 patients with phlegm and silting stasis type non alcohol fatty liver disease who were admitted to our hospital from February 2016 to September 2017 were randomly divided into treatment group（n=53）and control group（n=53）.The two groups were given basic treatment,on this basis,the control group took Silibin Meglumine Tablets,the treatment group was combined with Jiangzhi Huayu Decoction on the basis of the control group.The clinical efficacy,TCM syndrome scores,serum alanine aminotransferase（ALT）,aspartate aminotransferase（AST）,glutamyl transpeptidase（GGT）levels,blood lipid metabolism,and incidence rate of adverse reactions were comparedbetween the two groups.[Results]The total effective rate in the treatment group was 92.45%,which was higher than 71.70%in the control group（P0.05）;after treatment,the TCM symptom scores of the two groups were lower than that before treatment（P0.05）,and the treatment group was lower than the control group（P0.05）;serum ALT,AST and GGT levels after treatment were lower than that before treatment（P0.05）,and the treatment group was lower than the control group（P0.05）;after treatment,the levels of total cholesterol（TC）,triglyceride（TG）,high-density lipoprotein cholesterol（LDL-C）were lower than that before treatment（P0.05）,and low-density lipoprotein cholesterol（HDL-C）level was higher than that before treatment（P0.05）,and the differences between the two groups were statistically significant（P0.05）,the level of TC,TG and LDL-C in the treatment group was lower than that of the control group（P0.05）,and the level of HDL-C was higher than that of the control group（P0.05）;there was no significant difference in the incidence rate of adverse reactions between the treatment group a
作者
丁麟
蔡新吉
王巍
王秀艳
DING Lin;CAI Xin-ji;WANG Wei;WANG Xiu-yan(Department of Traditional Chinese Medicine,General Hospital of Jinan Military Area,Ji’ nan 250081,China)
出处
《中国中西医结合消化杂志》
CAS
2018年第7期561-565,共5页
Chinese Journal of Integrated Traditional and Western Medicine on Digestion
关键词
降脂化瘀汤
水飞蓟宾葡甲胺片
痰瘀互结型
非酒精性脂肪肝
血脂代谢
Jiangzhi Huayu decoction
silibin meglumine tablets
phlegm and silting stasis type
non alcohol fatty liver disease
blood lipid metabolism
